n-acetylglucosamine-thiazoline and nagstatin

The O-GlcNAc modification is found on many nucleocytoplasmic proteins. The dynamic nature of O-GlcNAc, which in some ways is reminiscent of phosphorylation, has enabled investigators to modulate the stoichiometry of O-GlcNAc on proteins in order to study its function. Although several genetic and pharmacological methods for manipulating O-GlcNAc levels have been described, one of the most direct approaches of increasing global O-GlcNAc levels is by using small-molecule inhibitors of O-GlcNAcase (OGA). As the interest in increasing O-GlcNAc levels has grown, so too has the number of OGA inhibitors. This review provides an overview of the available methods of increasing O-GlcNAc levels, with a special emphasis on inhibition of OGA by small molecules. Known inhibitors of OGA are discussed with particular attention on those most suitable for cell-based biological studies. Several examples in which OGA inhibitors have been used to study the functional role of the O-GlcNAc modification in biological systems are discussed, highlighting the pros and cons of different inhibitors.

Topics: Acetylglucosamine; Acetylglucosaminidase; Animals; Catalytic Domain; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; N-Acetylglucosaminyltransferases; Oximes; Phenylcarbamates; Pyrazoles; Pyridines; Streptozocin; Thiazoles; Uridine Diphosphate N-Acetylglucosamine